Northcape Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$770K Buy
27,430
+4,600
+20% +$122K 0.21% 84
2025
Q4
$568K Sell
22,830
-3,607
-14% -$91K 0.16% 94
2025
Q3
$674K Buy
26,437
+125
+0.5% +$3.08K 0.2% 84
2025
Q2
$638K Buy
26,312
+1,164
+5% +$27.1K 0.19% 88
2025
Q1
$637K Buy
25,148
+9,519
+61% +$249K 0.21% 87
2024
Q4
$415K Sell
15,629
-8,145
-34% -$221K 0.13% 104
2024
Q3
$688K Buy
23,774
+419
+2% +$12.2K 0.23% 84
2024
Q2
$653K Buy
23,355
+275
+1% +$7.57K 0.24% 82
2024
Q1
$640K Sell
23,080
-4,198
-15% -$116K 0.23% 82
2023
Q4
$785K Sell
27,278
-6,378
-19% -$193K 0.28% 78
2023
Q3
$1.12M Buy
33,656
+2,151
+7% +$76.1K 0.43% 67
2023
Q2
$1.16M Sell
31,505
-734
-2% -$28.6K 0.42% 65
2023
Q1
$1.32M Buy
32,239
+21,903
+212% +$946K 0.48% 64
2022
Q4
$530K Sell
10,336
-31,253
-75% -$1.5M 0.3% 61
2022
Q3
$1.82M Buy
41,589
+9,363
+29% +$455K 0.65% 57
2022
Q2
$1.69M Sell
32,226
-9,354
-22% -$477K 0.65% 51
2022
Q1
$2.15M Buy
41,580
+8,880
+27% +$461K 0.63% 51
2021
Q4
$1.93M Buy
+32,700
New +$1.62M 0.65% 52

Other funds holding PFE

Northcape Wealth Management's PFE Position: Q1 2026 in Review

Northcape Wealth Management increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $122K and bringing the position to 27,430 shares worth $770K. The position accounts for 0.21% of the portfolio, ranked #84.

Northcape Wealth Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.15M in Q1 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Northcape Wealth Management held 27,430 shares of Pfizer worth $770K as of Q1 2026.
  • Northcape Wealth Management bought 4,600 Pfizer shares in Q1 2026, an estimated $122K.
  • Pfizer made up 0.21% of Northcape Wealth Management's portfolio in Q1 2026, its #84 holding.
  • Northcape Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • Northcape Wealth Management's Pfizer position peaked at $2.15M in Q1 2022.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.